SkinBioTherapeutics
Developing and commercialising its technology platform.
Launch date
Employees
Market cap
CAD49.7m
Enterprise valuation
CAD45m (Public information from Sep 2024)
Share price
€0.112 5KW.F
Company register number 09632164
England United Kingdom (HQ)
Financials
Estimates*
| EUR | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
| Revenues | - | - | - | - | <1m | <1m | 1.3m |
| % growth | - | - | - | - | - | 77 % | 733 % |
| EBITDA | - | (1.6m) | (1.9m) | (1.8m) | (3.2m) | (3.5m) | (2.9m) |
| % EBITDA margin | - | - | - | - | (3580 %) | (2204 %) | (218 %) |
| Profit | (<1m) | (1.3m) | (1.8m) | (1.7m) | (3.0m) | (3.4m) | (3.2m) |
| % profit margin | - | - | - | - | (3380 %) | (2147 %) | (245 %) |
| EV / revenue | - | - | - | - | 424.7x | 163.9x | 26.2x |
| EV / EBITDA | - | -18.9x | -12.3x | -63.7x | -11.9x | -7.4x | -12.0x |
| R&D budget | <1m | <1m | <1m | <1m | 1.0m | 1.1m | - |
| R&D % of revenue | - | - | - | - | 1152 % | 705 % | - |
| Date | Investors | Amount | Round |
|---|---|---|---|
N/A | Spinout | ||
| N/A | €5.3m Valuation: €12.5m -2475.7x EV/LTM EBITDA | IPO | |
| N/A | N/A | Post IPO Equity | |
| N/A | £1.5m | Post IPO Equity | |
* | N/A | £2.5m | Private Placement VC |
* | £1.6m | Post IPO Equity | |
| Total Funding | CAD4.5m | ||
Related Content
Recent News about SkinBioTherapeutics
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.
Investments by SkinBioTherapeutics
Edit
ACQUISITION by SkinBioTherapeutics Jan 2024